GB202214646D0 - Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds - Google Patents
Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compoundsInfo
- Publication number
- GB202214646D0 GB202214646D0 GBGB2214646.8A GB202214646A GB202214646D0 GB 202214646 D0 GB202214646 D0 GB 202214646D0 GB 202214646 A GB202214646 A GB 202214646A GB 202214646 D0 GB202214646 D0 GB 202214646D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- methylthioninium
- utilising
- treatment
- containing compounds
- neurodegenerative disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2214646.8A GB202214646D0 (en) | 2022-10-05 | 2022-10-05 | Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds |
| PCT/EP2023/064369 WO2023232764A1 (en) | 2022-05-31 | 2023-05-30 | Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds |
| TW112120249A TW202410901A (en) | 2022-05-31 | 2023-05-31 | Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2214646.8A GB202214646D0 (en) | 2022-10-05 | 2022-10-05 | Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202214646D0 true GB202214646D0 (en) | 2022-11-16 |
Family
ID=84000003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2214646.8A Ceased GB202214646D0 (en) | 2022-05-31 | 2022-10-05 | Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB202214646D0 (en) |
-
2022
- 2022-10-05 GB GBGB2214646.8A patent/GB202214646D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202019418D0 (en) | Novel therapeutics for the treatment of neurodegenerative disorders | |
| IL285708A (en) | Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders | |
| IL288001A (en) | Compounds for the treatment of neurodegenerative and metabolic disorders | |
| IL311256A (en) | Methods and uses of microbiome compositions, components, or metabolites for treating neurodegenerative diseases | |
| GB202214646D0 (en) | Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds | |
| GB202208038D0 (en) | Treatment of neurodegenerative disorders utilising methylthioninium (MT)-containing compounds | |
| GB201914034D0 (en) | Treatment of neurological disorders | |
| EP4125968A4 (en) | Treatment of respiratory disorders | |
| GB202009618D0 (en) | Therapeutics for the treatment of FSHD | |
| EP3927342A4 (en) | Compounds and methods of deuterated xanomeline for treating neurological disorders | |
| EP3793548A4 (en) | Compounds for treatment of pancreatic cancer | |
| IL289201A (en) | Compounds for treatment of cancer | |
| KR102412352B9 (en) | ERR- Pharmaceutical Composition for Treatment of Leukemia Comprising ERR- Antagonist | |
| GB202010829D0 (en) | Compounds for treatment of neovascular diseases | |
| GB202315717D0 (en) | A composition for the treatment of a neurological disorder | |
| GB202307686D0 (en) | Treatment of conditions | |
| GB202117758D0 (en) | Therapeutics for the treatment of neurodegenerative disorders | |
| GB201912449D0 (en) | Compounds for treatment of neovascular diseases | |
| GB202318315D0 (en) | Method of treating an iridium containing effluent stream | |
| KR102583195B9 (en) | Composition Comprising Quinovic Acid for Preventing or Treating of Neurodegenerative Disease | |
| IL308424A (en) | Use of pelabresib for treating anemias | |
| IL310241A (en) | Treatment of lupus | |
| GB202215434D0 (en) | BEnzimadazole compound for the treatment of metabolic disorders | |
| GB202311827D0 (en) | Treatment of neuroblastoma | |
| GB202110146D0 (en) | Treatment of respiratory conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |